ProfileGDS4718 / 219912_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 22% 16% 22% 17% 18% 20% 24% 20% 16% 21% 14% 14% 18% 23% 21% 18% 20% 18% 26% 21% 20% 22% 18% 19% 21% 14% 21% 16% 15% 17% 18% 23% 15% 18% 21% 25% 21% 18% 7% 25% 22% 19% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0249116
GSM549102patient 115, normal, homogenized [OPG study]4.216922
GSM549104patient 119, normal, homogenized [OPG study]3.9862316
GSM549108patient 138, normal, homogenized [OPG study]4.2476122
GSM549119patient 077, normal, homogenized [OPG study]4.0399717
GSM549133patient 032, cancer, homogenized [OPG study]4.033418
GSM549139patient 042, cancer, homogenized [OPG study]4.1075120
GSM549099patient 107, normal, homogenized [OPG study]4.3209724
GSM549109patient 139, normal, homogenized [OPG study]4.1575620
GSM549110patient 046, normal, homogenized [OPG study]4.0022916
GSM549114patient 063, normal, homogenized [OPG study]4.1374721
GSM549122patient 082, normal, homogenized [OPG study]3.9520714
GSM549134patient 033, cancer, homogenized [OPG study]3.9192714
GSM549136patient 036, cancer, homogenized [OPG study]4.0132518
GSM549140patient 044, cancer, homogenized [OPG study]4.2225923
GSM549111patient 047, normal, homogenized [OPG study]4.1513521
GSM549113patient 057, normal, homogenized [OPG study]4.0157818
GSM549132patient 031, cancer, homogenized [OPG study]4.1165820
GSM549137patient 038, cancer, homogenized [OPG study]4.051818
GSM549142patient 047, cancer, homogenized [OPG study]4.4626326
GSM549100patient 110, normal, homogenized [OPG study]4.2044121
GSM549107patient 135, normal, homogenized [OPG study]4.1221920
GSM549115patient 068, normal, homogenized [OPG study]4.1612422
GSM549116patient 072, normal, homogenized [OPG study]4.0528418
GSM549120patient 078, normal, homogenized [OPG study]4.1159519
GSM549131patient 030, cancer, homogenized [OPG study]4.12921
GSM549118patient 074, normal, homogenized [OPG study]3.9178514
GSM549129patient 027, cancer, homogenized [OPG study]4.2095821
GSM549123patient 088, normal, homogenized [OPG study]3.9988216
GSM549124patient 006, cancer, homogenized [OPG study]3.9844315
GSM549126patient 015, cancer, homogenized [OPG study]4.0130217
GSM549128patient 025, cancer, homogenized [OPG study]4.0564618
GSM549103patient 117, normal, homogenized [OPG study]4.3154723
GSM549117patient 073, normal, homogenized [OPG study]3.9593315
GSM549138patient 041, cancer, homogenized [OPG study]4.0386718
GSM549141patient 045, cancer, homogenized [OPG study]4.1128321
GSM549130patient 028, cancer, homogenized [OPG study]4.3424625
GSM549101patient 111, normal, homogenized [OPG study]4.182121
GSM549105patient 128, normal, homogenized [OPG study]4.093218
GSM549106patient 134, normal, homogenized [OPG study]3.631727
GSM549112patient 048, normal, homogenized [OPG study]4.3161325
GSM549125patient 011, cancer, homogenized [OPG study]4.2516322
GSM549127patient 024, cancer, homogenized [OPG study]4.0878519
GSM549135patient 035, cancer, homogenized [OPG study]3.9336315